Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest globenewswire.com · 1 day ago

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

-- -11.6% mean reduction in BMI from baseline at Week 16 (n=7) -- -- BMI reductions consistent with setmelanotide and bivamelagon --

Press releases

More recent coverage

Page 60
R businesswire.com · 1 day ago

Ryder CEO John Diez to Address Deutsche Bank's Chicago Industrials Summit

MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder System, Inc. (NYSE: R) CEO John Diez to address Deutsche Bank's Chicago Industrials Summit. Who: Ryder System, Inc. CEO John Diez     What: Deutsche Bank's Chicago Industrials Summit     When: Tuesday, August 11, 2026     Time: 3:00 p.m. Central Time     Webcast: To access the live webcast, visit Ryder - Deutsche Bank's Chicago Industrials Summit. About Ryder System, Inc. Ryder System, Inc. (NYSE: R) is a nearly $13 billion leading provider of outsourced logistics.

SRFM businesswire.com · 1 day ago

Surf Air Mobility Publishes Updated Investor Presentation

LOS ANGELES--(BUSINESS WIRE)--Surf Air Mobility Inc. (NYSE: SRFM) (“Surf Air Mobility”), a leading air mobility platform, today announced it published an investor presentation to its Investor Relations website's ‘Events & Presentations' page which can be viewed here.About Surf Air MobilitySurf Air Mobility is a Los Angeles-based air mobility platform. With its AI-enabled SurfOS software, Surf Air Mobility provides technology designed to support the modernization of air operations and the ado.

PGPHF businesswire.com · 1 day ago

USA Compression Partners Reports Second-Quarter 2026 Results

DALLAS--(BUSINESS WIRE)--USA Compression Partners, LP (NYSE: USAC) (“USA Compression” or the “Partnership”) announced today its financial and operating results for second-quarter 2026. Financial Highlights Total revenues of $342.1 million for second-quarter 2026, compared to $250.1 million for second-quarter 2025. Net income was $45.7 million for second-quarter 2026, compared to $28.6 million for second-quarter 2025. Net cash provided by operating activities was $145.7 million for second-quarte.

TKR prnewswire.com · 1 day ago

Timken Reports Second-Quarter 2026 Results

Sales of $1.26 billion, up 7.5 percent from last year Second-quarter diluted EPS of $0.41; adjusted EPS of $1.83 Net income margin of 2.3 percent; adjusted EBITDA margin of 19.6 percent Updates 2026 EPS outlook; now expects 2026 EPS of $3.75-$4.05, raising adjusted EPS outlook to $6.05-$6.35 NORTH CANTON, Ohio, Aug. 4, 2026 /PRNewswire/ -- The Timken Company (NYSE: TKR) (www.timken.com), a leader in advanced motion technology, today reported second-quarter 2026 results. 2Q-26 2Q-25 % Change Net Sales (mils.

ENR prnewswire.com · 1 day ago

Energizer Holdings, Inc. Announces Fiscal 2026 Third Quarter Results

Third Quarter Highlights Net sales of $734.1 million, +1.2% to prior year and +2.7% organic increase(1) Gross Margin of 38.2% and 39.2% on an adjusted basis(1)  Earnings per share of $0.58 & Adjusted Earnings per share of $0.75(1) Updating fiscal year outlook for Adjusted Earnings per share and Adjusted EBITDA to the low end of the originally provided ranges(1) ST. LOUIS, Aug. 4, 2026 /PRNewswire/ -- Energizer Holdings, Inc. (NYSE: ENR) today announced results for the third fiscal quarter ended June 30, 2026.

KIM globenewswire.com · 1 day ago

Kimco Realty® Announces Second Quarter 2026 Results

– Strong Leasing Gains Drove Occupancy to All-time Highs – – Increases Common Dividend 12% Year-over-Year – – Raises 2026 Outlook – JERICHO, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Kimco Realty® (NYSE: KIM), a real estate investment trust (“REIT”) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, today reported results for the second quarter ended June 30, 2026.

VGNT businesswire.com · 1 day ago

Versigent Reports Second Quarter 2026 Results

SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today reported results for its second quarter ended June 30, 2026. Highlights Second Quarter 2026 Net sales of $2,444 million, up 10.8% year-over-year Adjusted Net Sales Growth1 of approximately 5% year-over-year Net income attributable to Versigent of $118 million, up 10.3% year-over-year Diluted Earnings Per Share of $1.64, Ad.

BNTX globenewswire.com · 1 day ago

BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

Guido Oelkers, Ph.D., appointed to BioNTech Management Board as Chief Executive Officer , taking office by February 1, 2027, at the latest Advanced diversified pipeline now with 14 ongoing pivotal clinical trials and more than ten novel-novel combinations across major tumor types Multiple milestones achieved in 2026, including initiation of six pivotal trials - five for pumitamig and one for B7-H3-targeting ADC candidate elfetabart drozuntecan ; upcoming 2026 catalysts include three late-stage readouts expected across immunomodulators, antibody-drug conjugate and mRNA cancer immunotherapies Pumitamig in combination with chemotherapy showed encouraging efficacy in first line non-small cell lung cancer and results presented at 2026 ASCO Annual Meeting became the third global pumitamig data set consistently showing efficacy across PD-L1 expression levels Approval received for new variant-adapted COVID-19 vaccine by the European Commission ; further launch preparation underway as recommended by regulators Second quarter 2026 revenues of €105.6 million1 , adjusted2 R&D expenses of €477.1 million (IFRS R&D expenses of €551.0 million), and adjusted SG&A 3 expenses of €197.8 million Revising full year 2026 financial guidance range for revenues to €1.6–1.9 billion, adjusted R&D expenses to €2.0–2.3 billion, and maintaining adjusted SG&A expenses of €700–800 million Maintained strong financial position with cash, cash equivalents and security investments of €16.6 billion 4 Conference call and webcast scheduled for August 4, 2026, at 8:00 a.m.

MPLX prnewswire.com · 1 day ago

MPLX LP Reports Second-Quarter 2026 Financial Results

FINDLAY, Ohio, Aug. 4, 2026 /PRNewswire/ -- Executing Natural Gas and NGL value chain growth strategy; Harmon Creek III processing plant beginning operations in August; progressing expansion of Permian sour gas treating capacity Second-quarter net income attributable to MPLX of $1.1 billion and net cash provided by operating activities of $1.7 billion Adjusted EBITDA attributable to MPLX of $1.8 billion and distributable cash flow of $1.5 billion, enabling the return of $1.1 billion of capital MPLX expects distribution increases of 12.5% in 2026 and 2027 MPLX LP (NYSE: MPLX) today reported second-quarter 2026 net income attributable to MPLX of $1,077 million, compared with $1,048 million for the second quarter of 2025. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) attributable to MPLX was $1,775 million, compared with $1,690 million for the second quarter of 2025.

FTI globenewswire.com · 1 day ago

Descartes Introduces New AI-Powered Free Trade Intelligence (FTI) Solution to Help Reduce Trade Costs

LONDON and ATLANTA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, introduced its new artificial intelligence (AI)-enabled Descartes Free Trade Intelligence™ (FTI) solution to help manufacturers, importers and exporters lower costs by making more informed sourcing and trade decisions. For organizations with enterprise resource planning (ERP) systems that lack comprehensive global trade management (GTM) capabilities, the solution helps qualify appropriate goods for preferential tariff treatment faster, maximize duty savings opportunities, and reduce compliance risk.

MPC prnewswire.com · 1 day ago

Marathon Petroleum Corp. Reports Second-Quarter 2026 Results

FINDLAY, Ohio, Aug. 4, 2026 /PRNewswire/ -- Second-quarter net income attributable to MPC of $5.1 billion, or $17.73 per diluted share $8.5 billion of adjusted EBITDA, with strong commercial and operational performance across the system Executing value-enhancing capital strategy; El Paso and Robinson yield-enhancing investments online in 2Q26, extending the competitive position of these refining assets Advancing MPLX Natural Gas and NGL value chain growth strategy, expected to support 12.5% annual distribution growth in 2026 and 2027 $2.8 billion of capital returned, reflecting strong cash generation and disciplined execution of our capital allocation priorities Marathon Petroleum Corp. (NYSE: MPC) today reported net income attributable to MPC of $5.1 billion, or $17.73 per diluted share, for the second quarter of 2026. This compares with a net income attributable to MPC of $1.2 billion, or $3.96 per diluted share, for the second quarter of 2025.

SOPH prnewswire.com · 1 day ago

SOPHiA GENETICS Reports Second Quarter 2026 Results

BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Revenue was $23.3 million, up 27% year-over-year Gross margin was 64.6% on a reported basis and 72.1% on an adjusted basis, compared to 67.0% reported and 74.4% adjusted in the prior year period Net loss was $22.4 million, flat year-over-year; Adjusted EBITDA loss was $8.8 million, improving 27% year-over-year The company is raising 2026 revenue guidance to a range of $94 million to $96 million, representing 22% to 24% year-over-year growth.

PFE businesswire.com · 1 day ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for the second quarter of 2026 and raised its full-year 2026 Revenue guidance by $500 million at the midpoint while reaffirming guidance(2) for Adjusted(3) diluted EPS, which absorbs an impact of approximately $0.10 related to the Innovent Biologics, Inc. transaction. EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and CEO of Pfizer: “Pfizer had another strong quarter, delivering on our financial commitments and adva.

APTV businesswire.com · 1 day ago

Aptiv Reports Second Quarter 2026 Financial Results

SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Aptiv PLC (NYSE: APTV), a global industrial technology company, today reported financial results for the second quarter of 2026. Second Quarter Financial Highlights Include: U.S. GAAP revenue of $3.3 billion, an increase of 2% Adjusted revenue growth of 2% U.S. GAAP net income from continuing operations of $298 million Adjusted EBITDA of $613 million U.S. GAAP diluted earnings per share from continuing operations of $1.40 Adjusted net income per share.

← Newer
Older →